Author

C. Nam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

D. Lin· 2 shared H. Zhao· 2 shared Y. Zheng· 2 shared B. Ziman· 1 shared J. H. Um· 1 shared M. Sheth· 1 shared Q. Mao· 1 shared Q. Yang· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Lin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma

J. H. Um, Y. Zheng, Q. Mao, C. Nam, H. Zhao, Y. W. Koh, S.-J. Shin, Y. M. Park, D. Lin

This study establishes patient-derived tumor organoids (PDOs) from 31 HNSCC patients, faithfully recapitulating tumor characteristics and predicting cisplatin responses, revealing hEMT-driven resistance and AREG as a therapeutic target.

bioRxiv · Jun 28, 2024 · PreprintCancer Biology

Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma

B. Ziman, Q. Yang, Y. Zheng, M. Sheth, C. Nam, H. Zhao, U. Sinha, D. Lin

This study identifies FOXM1 as an epigenetic regulator in EAC that suppresses anti-tumor immune responses by inhibiting CD8+ T cell infiltration and function.

bioRxiv · Jul 28, 2023Cancer Biology